LegoChem Biosciences Inc (141080)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:LegoChem Biosciences Inc (141080) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014106
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
LegoChem Biosciences Inc (LCB) is a drug company that research and develops small molecule drugs. The company’s services include joint and contract research, chemical library package, compound synthesis and sales, and screening services. Its screening services include metabolic stability, plasma stability, protein binding, and cell toxicity. LCB also offers compound synthesis and process development services. The company manufactures drugs in the therapeutic areas of antibiotics, anticoagulants, anticancer and anti-inflammation. It conducts research programs through co-developments, joint researches, and global pharmaceutical companies. The company serves in different parts of Korea. LCB is headquartered in Daejeon, South Korea.

LegoChem Biosciences Inc (141080) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Novimmune and LegoChem Biosciences Enter into Research Agreement 11
Nordic Nanovector Enters into Partnership with LegoChem Biosciences 12
LegoChem Biosciences Enters into Joint Venture Agreement with Geom Therapeutics 13
Y-Biologics Enters into Agreement with LegoChem Biosciences 14
LegoChem Biosciences Enters into Agreement with Theranyx 15
Seasun Biomaterials Enters into Agreement with LegoChem Biosciences 16
LegoChem, Longthera and Medicilon Form Collaboration to Co-Develop LCB01-0699 17
AstraZeneca Enters into Agreement with LegoChem for Antibiotic-Resistant Bacterial Infections 18
Licensing Agreements 19
Geom Therapeutics Enters into Licensing Agreement with LegoChem Biosciences 19
Bridge Biotherapeutics Enters into Licensing Agreement with LegoChem Biosciences 20
Millennium Pharma Enters into Licensing Agreement with LegoChem Biosciences 21
LegoChem Biosciences Enters Licensing Agreement with RMX Biopharma 22
Shanghai Fosun Pharma Enters into Licensing Agreement with LegoChem Biosciences 23
Equity Offering 24
LegoChem Biosciences Raises USD4.2 Million in Rights Offering 24
LegoChem Biosciences Raises USD21.8 Million in Private Placement of Shares 25
Debt Offering 26
LegoChem Biosciences Raises USD9.3 Million in Private Placement of Bonds 26
LegoChem Biosciences Inc – Key Competitors 27
LegoChem Biosciences Inc – Key Employees 28
LegoChem Biosciences Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
LegoChem Biosciences Inc, Deals By Therapy Area, 2011 to YTD 2017 8
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Novimmune and LegoChem Biosciences Enter into Research Agreement 11
Nordic Nanovector Enters into Partnership with LegoChem Biosciences 12
LegoChem Biosciences Enters into Joint Venture Agreement with Geom Therapeutics 13
Y-Biologics Enters into Agreement with LegoChem Biosciences 14
LegoChem Biosciences Enters into Agreement with Theranyx 15
Seasun Biomaterials Enters into Agreement with LegoChem Biosciences 16
LegoChem, Longthera and Medicilon Form Collaboration to Co-Develop LCB01-0699 17
AstraZeneca Enters into Agreement with LegoChem for Antibiotic-Resistant Bacterial Infections 18
Geom Therapeutics Enters into Licensing Agreement with LegoChem Biosciences 19
Bridge Biotherapeutics Enters into Licensing Agreement with LegoChem Biosciences 20
Millennium Pharma Enters into Licensing Agreement with LegoChem Biosciences 21
LegoChem Biosciences Enters Licensing Agreement with RMX Biopharma 22
Shanghai Fosun Pharma Enters into Licensing Agreement with LegoChem Biosciences 23
LegoChem Biosciences Raises USD4.2 Million in Rights Offering 24
LegoChem Biosciences Raises USD21.8 Million in Private Placement of Shares 25
LegoChem Biosciences Raises USD9.3 Million in Private Placement of Bonds 26
LegoChem Biosciences Inc, Key Competitors 27
LegoChem Biosciences Inc, Key Employees 28
LegoChem Biosciences Inc, Other Locations 29

★海外企業調査レポート[LegoChem Biosciences Inc (141080)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Karoon Gas Australia Ltd (KAR):石油・ガス:M&Aディール及び事業提携情報
    Summary Karoon Gas Australia Ltd (Karoon) is a major independent upstream oil and gas company, which explores for oil and gas and develops assets. It also operates projects in Brazil and Peru. Karoon has significant drilling opportunities in proven and prospective petroleum systems. The company focu …
  • HDR Inc:企業の戦略的SWOT分析
    HDR Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Electric Power Development Co Ltd (9513):企業の財務・戦略的SWOT分析
    Electric Power Development Co Ltd (9513) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Escorts Ltd:企業の戦略・SWOT・財務情報
    Escorts Ltd - Strategy, SWOT and Corporate Finance Report Summary Escorts Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Catalyst Biosciences Inc:企業のM&A・事業提携・投資動向
    Catalyst Biosciences Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Catalyst Biosciences Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Smiths Group plc:企業の戦略・SWOT・財務分析
    Smiths Group plc - Strategy, SWOT and Corporate Finance Report Summary Smiths Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Insurance Corporation Of British Columbia:企業の戦略・SWOT・財務情報
    Insurance Corporation Of British Columbia - Strategy, SWOT and Corporate Finance Report Summary Insurance Corporation Of British Columbia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Derma Sciences Inc-医療機器分野:企業M&A・提携分析
    Summary Derma Sciences Inc (Derma Sciences) is a medical devices company. It focuses on advanced wound care and traditional wound care. Its advanced wound care product portfolio includes dermagran, silverseal, alginate dressing, aquasite hydrogel, primacol hydrocolloid, hydrocell foam and primaderm …
  • Imperial Brands Plc:企業のM&A・事業提携・投資動向
    Imperial Brands Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Imperial Brands Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Arla Foods Ingredients Group P/S:企業の戦略・SWOT・財務情報
    Arla Foods Ingredients Group P/S - Strategy, SWOT and Corporate Finance Report Summary Arla Foods Ingredients Group P/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Siegfried Holding AG (SFZN):製薬・医療:M&Aディール及び事業提携情報
    Summary Siegfried Holding AG (Siegfried) is a custom manufacturing organization (CMO). The company is active in the primary and secondary production of drugs. It develops and manufactures active pharmaceutical ingredients (APIs) for the research-based pharmaceutical industry and corresponding interm …
  • Live Nation Entertainment, Inc.:企業のM&A・事業提携・投資動向
    Live Nation Entertainment, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Live Nation Entertainment, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Centerchem Inc:企業の戦略・SWOT・財務情報
    Centerchem Inc - Strategy, SWOT and Corporate Finance Report Summary Centerchem Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Constellium NV:企業の戦略・SWOT・財務分析
    Constellium NV - Strategy, SWOT and Corporate Finance Report Summary Constellium NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Aeglea BioTherapeutics Inc (AGLE)-製薬・医療分野:企業M&A・提携分析
    Summary Aeglea BioTherapeutics Inc (Aeglea BioTherapeutics), formerly Aeglea BioTherapeutics Holdings, LLC is a biotechnology company that develops and commercializes engineered human enzymes for the treatment of cancer and rare genetic diseases. The company’s product pipeline comprises AEB1102, AEB …
  • GENEWIZ Inc:医療機器:M&Aディール及び事業提携情報
    Summary GENEWIZ Inc (GENEWIZ) is a provider of genomics and technical support services. The company’s services comprise next generation sequencing, sanger sequencing, gene synthesis, molecular genetics, cloning and mutagenesis, plasmid DNA preparation, oligo synthesis services and GLP-compliant serv …
  • Verizon Connect:企業の戦略的SWOT分析
    Verizon Connect - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Clean Diesel Technologies Inc (CDTI):企業の財務・戦略的SWOT分析
    Summary Clean Diesel Technologies Inc (CDTI) is a clean technology company that manufactures and distributes heavy duty diesel and light duty vehicle emissions control systems and products to automakers and retrofitters. The company's products include catalyst products, heavy duty diesel products, a …
  • Smurfit Kappa Group plc:企業のM&A・事業提携・投資動向
    Smurfit Kappa Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Smurfit Kappa Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Muehlbauer Holding AG & Co. KGaA (MUB):企業の財務・戦略的SWOT分析
    Muehlbauer Holding AG & Co. KGaA (MUB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆